Abstract
In recent times, bee venom (BV) from honey bee (Apis mellifera L.) has become the focus of interest as a form of alternative and preventive medicine for the treatment of a number of clinical cases such as arthritis, rheumatism, pain, cancer and a vast range of other conditions. BV contains several biochemically and pharmacologically active substances. Some of these compounds are well studied and their mechanisms of action established, despite the fact that few are undergoing clinical trials. Scientists are now performing intensive research work especially human clinical trials to improve the potential use of BV and its chemical constituents as the next drugs generation in the treatment of chronic disorders. Nevertheless, the dual effect of some bee venom components is also important in the design of future therapeutic goals. This paper gives recent evidences on the chemical and biological properties of the major components of bee venom, their underlying molecular action mechanism, and reasons of its consideration as a promising alternative medicine.
Keywords: Alternative medicine, bee venom, biological properties, clinical trials, chronic disorders, molecular mechanism.
Anti-Infective Agents
Title:Bee Venom: Its Potential Use in Alternative Medicine
Volume: 13 Issue: 1
Author(s): Yuva Bellik
Affiliation:
Keywords: Alternative medicine, bee venom, biological properties, clinical trials, chronic disorders, molecular mechanism.
Abstract: In recent times, bee venom (BV) from honey bee (Apis mellifera L.) has become the focus of interest as a form of alternative and preventive medicine for the treatment of a number of clinical cases such as arthritis, rheumatism, pain, cancer and a vast range of other conditions. BV contains several biochemically and pharmacologically active substances. Some of these compounds are well studied and their mechanisms of action established, despite the fact that few are undergoing clinical trials. Scientists are now performing intensive research work especially human clinical trials to improve the potential use of BV and its chemical constituents as the next drugs generation in the treatment of chronic disorders. Nevertheless, the dual effect of some bee venom components is also important in the design of future therapeutic goals. This paper gives recent evidences on the chemical and biological properties of the major components of bee venom, their underlying molecular action mechanism, and reasons of its consideration as a promising alternative medicine.
Export Options
About this article
Cite this article as:
Bellik Yuva, Bee Venom: Its Potential Use in Alternative Medicine, Anti-Infective Agents 2015; 13 (1) . https://dx.doi.org/10.2174/2211352513666150318234624
DOI https://dx.doi.org/10.2174/2211352513666150318234624 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Sentinel Node Imaging
Current Medical Imaging Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies
Current Cancer Drug Targets Newer Avenues for the Treatment of Leptomeningeal Carcinomatosis
Central Nervous System Agents in Medicinal Chemistry New Platinum and Ruthenium Complexes - the Latest Class of Potential Chemotherapeutic Drugs - a Review of Recent Developments in the Field
Mini-Reviews in Medicinal Chemistry Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets Analysis of Taiwan Patents for the Medicinal Mushroom “Niu-Chang- Chih”
Recent Patents on Food, Nutrition & Agriculture Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells
Current Drug Targets Telocytes as a Source of Progenitor Cells in Regeneration and Repair Through Granulation Tissue
Current Stem Cell Research & Therapy Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Current Drug Targets GCPII Imaging and Cancer
Current Medicinal Chemistry A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches
Current Drug Targets Group-sparse Modeling Drug-kinase Networks for Predicting Combinatorial Drug Sensitivity in Cancer Cells
Current Bioinformatics Anatomical, Biochemical and Physiological Considerations of the Colon in Design and Development of Novel Drug Delivery Systems
Current Drug Delivery TEM8 Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design